Diabetes & Endocrinology Associates P C is categorized under Diabetes Doctors in Indianapolis, IN and active since 1986.
Diabetes & Endocrinology Associates P C was established in 1986, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Diabetes Doctors business, which does work in the B2C market, and is classified as a Diabetes Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Corbin Roudebush at the company’s single location by writing to 9240 North Meridian St # 200, Indianapolis, Indiana IN 46260 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Diabetes & Endocrinology Associates P C |
Contact Person: | Corbin Roudebush |
Address: | 9240 North Meridian St # 200, Indianapolis, Indiana 46260 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1986 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Diabetes Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Diabetes & Endocrinology Associates P C was started in 1986 to provide professional Diabetes Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Corbin Roudebush for inquiries that concern Diabetes & Endocrinology Associates P C by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Diabetes & Endocrinology Associates P C can be found at the coordinates as well as the street address 9240 North Meridian St # 200 in Indianapolis, Indiana 46260.
For its online presence, you may visit Diabetes & Endocrinology Associates P C’s website at and engage with its social media outlets through on Twitter and on Facebook.